Presentation TCT 2017 When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies Presenter: Robert A. Harrington, Kurt Huber, Michael D. Ezekowitz November 01, 2017
Presentation TCT 2017 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI Presenter: Robert A. Harrington, Kurt Huber, Christopher B. Granger November 01, 2017
Presentation TCT 2017 DECISION-CTO and EURO-CTO: Critique and Unanswered Questions Presenter: David J. Cohen, Ajay J. Kirtane, Emmanouil S. Brilakis November 01, 2017
Presentation TCT 2017 When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy? Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran November 01, 2017
Presentation TCT 2017 DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications Presenter: David J. Cohen, Ajay J. Kirtane, Gerald S. Werner November 01, 2017
Presentation TCT 2017 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: Robert A. Harrington, Kurt Huber, Michelle O'Donoghue November 01, 2017
Presentation TCT 2017 Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More Presenter: Robert A. Harrington, Kurt Huber, Didier Carrié November 01, 2017
Presentation TCT 2017 Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence? Presenter: Robert A. Harrington, Kurt Huber, Jean-François Tanguay November 01, 2017
News Conference News TCT 2017 Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES Todd Neale November 01, 2017
Presentation TCT 2017 What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt November 01, 2017
Presentation TCT 2017 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes November 01, 2017
Presentation TCT 2017 Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq November 01, 2017
Presentation TCT 2017 Transcatheter Tricuspid Intervention With a Twist Presenter: A. Pieter Kappetein, Georg Nickenig, Duane S. Pinto November 01, 2017
Presentation TCT 2017 Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat? Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq November 01, 2017
Presentation TCT 2017 MitraClip or TAVR With Left Atrial Appendage Closure Presenter: A. Pieter Kappetein, Georg Nickenig, Ramon Quesada November 01, 2017
Presentation TCT 2017 Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy? Presenter: A. Pieter Kappetein, Georg Nickenig, Joachim Schofer November 01, 2017
Presentation TCT 2017 Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat? Presenter: David J. Maron, Alan C. Yeung, Frederick Feit November 01, 2017
Presentation TCT 2017 Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn November 01, 2017
Presentation TCT 2017 Concomitant Severe Tricuspid and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy? Presenter: A. Pieter Kappetein, Georg Nickenig, Maurizio Taramasso November 01, 2017
Presentation TCT 2017 No Longer an Interventionalist? Try Something Else Presenter: Michael J. Rinaldi, David O. Williams, David P. Faxon November 01, 2017